Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
Katherine McMahan, Victoria Giffin, Lisa H. Tostanoski, et al.
Med (2022) Vol. 3, Iss. 4, pp. 262-268.e4
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 342
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 282
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 9-17.e3
Open Access | Times Cited: 245
Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas
Paul Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 4, pp. 642-652
Open Access | Times Cited: 203
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Christoph Jung, Dorota Kmieć, Lennart Koepke, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 203
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Rahul K. Suryawanshi, Irene P. Chen, Tongcui Ma, et al.
Nature (2022) Vol. 607, Iss. 7918, pp. 351-355
Open Access | Times Cited: 181
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 179
The Evolution and Biology of SARS-CoV-2 Variants
Amalio Telenti, Emma B. Hodcroft, David L. Robertson
Cold Spring Harbor Perspectives in Medicine (2022) Vol. 12, Iss. 5, pp. a041390-a041390
Open Access | Times Cited: 158
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Alexander Wilhelm, Marek Widera, Katharina Grikscheit, et al.
EBioMedicine (2022) Vol. 82, pp. 104158-104158
Open Access | Times Cited: 148
Milder disease with Omicron: is it the virus or the pre-existing immunity?
Alex Sigal
Nature reviews. Immunology (2022) Vol. 22, Iss. 2, pp. 69-71
Open Access | Times Cited: 147
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
John P. Evans, Cong Zeng, Panke Qu, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 8, pp. 1093-1102.e3
Open Access | Times Cited: 131
Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines
Yannic C. Bartsch, Xin Tong, Jaewon Kang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 642
Open Access | Times Cited: 115
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
Rana Abdelnabi, Caroline S. Foo, Xin Zhang, et al.
Antiviral Research (2022) Vol. 198, pp. 105253-105253
Open Access | Times Cited: 115
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
Yifei Guo, Jiajia Han, Yao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 103
Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 100
SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters
Federico Armando, Georg Beythien, Franziska Kaiser, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 97
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 96
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
Karina-Doris Vihta, Koen B. Pouwels, Tim Peto, et al.
Clinical Infectious Diseases (2022)
Open Access | Times Cited: 90
Omicron adopts a different strategy from Delta and other variants to adapt to host
Xiaohong Du, Haijun Tang, Long Gao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 88
Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 80
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
Vladimir N. Uversky, Elrashdy M. Redwan, William Makis, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 991-991
Open Access | Times Cited: 80
COVID-19–Associated Croup in Children
Ryan Brewster, Chase Parsons, Jess Laird-Gion, et al.
PEDIATRICS (2022) Vol. 149, Iss. 6
Closed Access | Times Cited: 78
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
Annabel Powell, Freja Kirsebom, Julia Stowe, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. 435-444
Open Access | Times Cited: 76
Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England
Zachary H. Strasser, Noah Greifer, Aboozar Hadavand, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2238354-e2238354
Open Access | Times Cited: 70
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6
Taha Y. Taha, Irene P. Chen, Jennifer M. Hayashi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top